TRIB

Trinity Biotech PLC

SPECULATIVE BUY Analysis generated 2026-10-28 Market data as of 2026-11-12 Market data 3 days old USD 5.88 Healthcare - Medical - Diagnostics & ResearchAWAIT ENTRY

ACTIONABLEMethodology gates passed

Position levels

Currenttoday

USD 5.88

Buy <=wait / entry

USD 4.93

Trim >=take some off

USD 7.80

Thesis breakA dilutive capital raise, failure to convert the nine million-test TrinScreen HI...

Scenario-weighted conviction

	Probability	Score	Contribution
Bull case	16%	100 / 100	16.0
Base case	48%	62 / 100	29.8
Bear case	36%	10 / 100	3.6
Weighted conviction			49 / 100 - SPECULATIVE BUY

Top risks

Trinovium subsidiary collaboration with Echelon Data Centres to develop advanced liquid cooling solutions
Partnership with Latch Medical to advance biosensor-guided precision drug delivery
Contract to supply Red Team Investments with advanced liquid cooling solutions

Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.